@article{26ae3bbb64c646c3a3663a68c6c157d9,
title = "Atrial Fibrillation Diagnosed following Stroke: Dealing with a New Clinical Entity or Just a Matter of Definition?",
author = "Harrison, {Stephanie L.} and Buckley, {Benjamin J.R.} and Riccardo Proietti and Lip, {Gregory Y.H.}",
note = "Funding Information: S.L.H. received funding from Bristol Myers Squibb (BMS) outside of the submitted work. B.J.R.B. received funding from BMS/Pfizer outside of the submitted work. G.Y.H.L. consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo and speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received to G.Y.H.L. personally. R.P. declare that there are no conflicts of interest. G.Y.H.L. is an Associate Editor for Cerebrovascular Diseases. ",
year = "2022",
month = mar,
day = "1",
doi = "10.1159/000520667",
language = "English",
volume = "51",
pages = "149--151",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "2",
}